Compare ABCL & FIGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | FIGS |
|---|---|---|
| Founded | 2012 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.4B |
| IPO Year | 2020 | 2021 |
| Metric | ABCL | FIGS |
|---|---|---|
| Price | $9.66 | $19.84 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 10 |
| Target Price | $18.69 | ★ $23.22 |
| AVG Volume (30 Days) | 2.8M | ★ 3.5M |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 850.00 |
| EPS | N/A | ★ 0.28 |
| Revenue | $75,128,000.00 | ★ $419,591,000.00 |
| Revenue This Year | N/A | $23.67 |
| Revenue Next Year | $13.74 | $10.78 |
| P/E Ratio | ★ N/A | $72.71 |
| Revenue Growth | ★ 160.56 | 59.47 |
| 52 Week Low | $2.75 | $9.17 |
| 52 Week High | $14.98 | $23.77 |
| Indicator | ABCL | FIGS |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 47.45 |
| Support Level | $3.45 | $19.41 |
| Resistance Level | $12.91 | $23.11 |
| Average True Range (ATR) | 0.84 | 1.34 |
| MACD | -0.22 | -0.43 |
| Stochastic Oscillator | 2.41 | 8.38 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
FIGS Inc is a healthcare apparel company. It designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other healthcare apparel. The company sells products mainly through its direct-to-consumer (DTC) digital platform, consisting of its website, mobile app, and B2B business (TEAMS). It also operates physical retail stores, which are called Community Hubs, providing a retail experience for healthcare professionals. The company generates maximum revenue from the sale of scrubwear products. Geographically, it derives maximum revenue from the United States, followed by the rest of the world.